Trial Profile
Relative Bioavailability and Comparative Pharmacokinetics of 13-CRA Oral Liquid and Extracted Capsule Formulations: a Randomised, Open Label, Multi-dose, Cross-over Clinical Trial in Patients Requiring Treatment Cycles of 13-CRA.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 21 Oct 2021
Price :
$35
*
At a glance
- Drugs Isotretinoin (Primary) ; Isotretinoin
- Indications Neuroblastoma
- Focus Pharmacokinetics
- Acronyms My-CRA
- Sponsors Nova Laboratories
- 17 Jan 2020 Status changed from active, no longer recruiting to completed.
- 22 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 21 Nov 2018 Status changed from not yet recruiting to recruiting.